secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avantor, Inc. (AVTR)
CIK:        0001722482
Form:       8-K
Filed at:   2023-09-26T23:59:59+00:00
Accession:  0001722482-23-000179
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avantor EVP Biopharma Production Gerard Brophy to retire, step down Oct 2, 2023
-------------------------------------------------------------------------------

- Gerard Brophy will step down as EVP Biopharma Production on October 2, 2023.
- He will retire from the company effective February 29, 2024.
- After retirement, Brophy will remain Chair of the Scientific Advisory Board and advisor to the company.
- Brophy was a named executive officer in Avantor's 2023 proxy statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1722482/000172248223000179/0001722482-23-000179-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1722482/000172248223000179/avtr-20230921.htm
  HTML page:      https://secwatch.observer/filing/0001722482-23-000179

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer